Lv72
4687 积分 2022-02-12 加入
Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab–Based Treatment in Patients With Metastatic Non-Small Cell Lung Cancer and Tumor PD-L1 <1%: a Pooled Analysis
2小时前
待确认
Improved Clinical Outcomes with Low-Dose Anti–CTLA-4 (Nurulimab) Plus Anti–PD-1 (Prolgolimab) vs. Anti–PD-1 Monotherapy in Advanced Cutaneous Melanoma: Results from the Phase III OCTAVA Trial
4小时前
待确认
CCR8: a promising therapeutic target against tumor-infiltrating regulatory T cells
1天前
待确认
A next-generation anti-CTLA-4 probody mitigates toxicity and enhances anti-tumor immunity in mice
1天前
待确认
An Anti-EGFR Antibody-Drug Radioconjugate Labeled with Actinium-225 Elicits Durable Anti-Tumor Responses in KRAS and BRAF Mutant Colorectal Cancer
14天前
已完结
Complete remissions of HER2-positive trastuzumab-resistant xenografts using a potent [225Ac]Ac-labeled anti-HER2 antibody-drug radioconjugate
14天前
已完结
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation
14天前
已完结
NSGS mice humanized with cord blood mononuclear cells show sustained and functional myeloid–lymphoid representation with limited graft-versus-host disease
14天前
已完结
Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of neurological disorders
15天前
已完结
Guardians of the brain: how a special immune system protects our grey matter
15天前
已完结
皖公网安备34019202002308
